Select login type
xCHOOSE A PAGE TO ACCESS
x- WGXVI Development Safety Update Report Working Group Documents
- Pharmacoepidemiology for Public Health Working Group Documents
- WGXII Benefit-risk Working Group Documents
- Good Governance Practice for Research Institutions Working Group Documents
- Educational Standards Working Group Documents
- SCAR Working Group Documents
- WGXIII Real-world Data Working Group Documents
- WGXII Benefit-risk Working Group Documents
- MedDRA Labelling Groupings Working Group Documents
- WGXI Patient Involvement: Workplans, drafts, TC notes ...
- WGXI Patient Involvement: Background Documents
- WGXI Patient Involvement: Face-to-face meetings
- Clinical Research in Resource-limited Settings Working Group Documents
- Login
Drug Safety
- Home
- Drug Safety
Aggregation of adverse event terms for signal detection and labeling in clinical trials. (Requires subscription).
See also the CIOMS report on MedDRA Labeling Grouping (reference 40 in the publication)